ODX.L Regulatory News (ODX)

Omega Diagnostics Group PLC

("Omega" or "the Company" or the "Group")

Allersys Distribution Agreement

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has signed a global distribution agreement with Immunodiagnostic Systems Limited ("IDS") for its Allersys® range of allergy assays.

The partnership with IDS is a long-term supply agreement and the Company now looks forward to working with IDS to introduce the initial launch panel of 51 allergy tests into the market.

Omega will continue to develop new assays to provide regular updates to the IDS instrument menu to increase its competitiveness by offering a broader range of tests.

Colin King, CEO of Omega commented: "I am pleased that we have finally concluded a deal with IDS to become our exclusive distributor for our Allersys® product range. Whilst we expect modest sales growth in the short term as we work together to further expand our menu, we are excited that with our development capability and IDS instrument and commercial expertise we can make a significant difference within the Allergy testing market. We believe our product offers a more flexible and efficient work-flow solution for small to mid-size laboratories."

The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

Contacts: